Longitudinal Evaluation of GTP1 as a PET Radioligand for Imaging Tau in the Brains of Patients With Prodromal, Mild, and Moderate Alzheimer's Disease Compared to Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2016
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Genentech
- 07 Jun 2017 Biomarkers information updated
- 02 Aug 2016 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.
- 02 Aug 2016 Planned primary completion date changed from 1 Nov 2017 to 1 Jan 2018.